Biocept reported $-5545000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US USD 1.44B 583M
Becton, Dickinson and BDX:US USD 288M 72M
Biocept BIOC:US USD -5545000 293K
Cytori Therapeutics CYTX:US USD -5219000 63K
General Electric GE:US USD -165000000 625M
Illumina ILMN:US USD -3816000000 3.28B
Quest Diagnostics DGX:US USD 256M 22M
Roche Holding ROG:VX 8.53B 2.4B
Thermo Fisher Scientific TMO:US USD 1.5B 169M